trending Market Intelligence /marketintelligence/en/news-insights/trending/7-Hv-U_V8LcV24dzNtxnwQ2 content esgSubNav
In This List

CytoSorbents names chief medical officer

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


CytoSorbents names chief medical officer

Eric Mortensen will become Cytosorbents Corp.'s chief medical officer on June 1, succeeding Robert Bartlett, who is retiring.

Bartlett will continue working with the company as a consultant and as co-chair of the cardiac surgery advisory board with Joseph Zwischenberger.

Mortensen is the former vice president and therapeutic area clinical head for inflammation and immunology at Pfizer Inc.